BTCRC-BRE15-024
- Adv. AR+ triple neg. breast cancer
- Sponsor-Investigator:
Ruth O'Regan, MD (Wisconsin)
|
BTCRC-BRE16-042
- Adv. HR+ HER2- breast cancer
- Sponsor-Investigator:
Nancy Chan, MD (Rutgers)
|
BTCRC-GI15-015
- Adv. gastric, gastroesophageal junction cancer
- Sponsor-Investigator:
Halla Nimeiri, MD (Northwestern)
|
BTCRC-GU15-023
- Adv. bladder cancer
- Sponsor-Investigator:
Monika Joshi, MD, MRCP (Penn State)
|
BTCRC-GYN15-013
- Adv./recurrent endometrial cancer
- Sponsor-Investigator:
Mario Pineda, MD, PhD (Northwestern)
|
BTCRC-LUN15-017
- Non-small cell lung cancer
- Sponsor-Investigator:
Lawrence Feldman, MD (Illinois)
|
BTCRC-LUN15-025
- Mesothelioma
- Sponsor-Investigator:
Arkadiusz Dudek, MD, PhD (Illinois)
|
BTCRC-LUN15-029
- Adv. non-small cell lung cancer
- Sponsor-Investigator:
Greg Durm, MD (Indiana)
|
To Join a Clinical Trial Working Group or Submit an LOI: Contact Anita Borek at
aborek@bigtencrc.org
or
317-634-5842, ext. 48.
|
Team up with the Big Ten Cancer Research Consortium. Together, we can make a big impact!
|
|
|
|
Investigators, industry leaders collaborate at BTCRC Summit
|
The first-ever
Big Ten Cancer Research Consortium Summit drew an energetic group of academic investigators and pharmaceutical industry leaders to Indianapolis Sept. 9-10, for a series of meetings that strengthened academic and pharmaceutical industry collaboration within the consortium. More than 100 attendees, representing all BTCRC member institutions and 16 pharmaceutical and biotech companies, participated in the summit hosted by the Indiana University Melvin and Bren Simon Cancer Center.
Read more
.
|
Fearon named cancer center director at University of Michigan
|
Eric Fearon, MD, PhD, has been named director of the University of Michigan Comprehensive Cancer Center.
Fearon, the Emanuel N. Maisel Professor of Oncology at the University of Michigan, is a nationally recognized investigator in cancer genetics. His research has led to a greater understanding of gene defects that cause colon and rectal cancer to develop and spread.
Read more
.
|
Milhem joins Steering Committee
|
Mohammed Milhem, MBBS, has joined the Big Ten Cancer Research Consortium Steering Committee, representing the Holden Comprehensive Cancer Center at the University of Iowa. The committee, composed of one representative from each member institution, meets on a regular basis to review activities of the consortium and decide matters of policy. The committee determines the criteria for approving concepts for development within the BTCRC.
Read more
.
|
Coalition unites to change perception of clinical trials
|
Studies show that patients with low income, the elderly, racial and ethnic minorities, women, and those who live in rural areas represent the smallest percentage of clinical trial participants. Unfortunately, these groups also represent a disproportionate burden of disease. A diverse coalition of health care partners that includes the Big Ten Cancer Research Consortium
recently announced the #BeAGift awareness campaign aimed at changing perceptions of and encouraging participation in clinical trials.
Learn more
.
|
Fred & Pamela Buffett Cancer Center
(University of Nebraska)
|
Get to know
Jean Grem, MD, professor of medicine at the University of Nebraska Medical Center.
Kenneth H. Cowan, MD, PhD, director of Fred & Pamela Buffett Cancer Center, shares thoughts on precision medicine, translational research, and access to clinical trials.
Read more.
|
Masonic Cancer Center (University of Minnesota)
|
Get to know
Stephen Hecht, PhD, a Carcinogenesis & Chemoprevention Research Program member at Masonic Cancer Center and Wallin Land Grant Professor of Cancer Prevention at UMN Department of Laboratory Medicine and Pathology.
Douglas Yee, MD, director of Masonic Cancer Center, discusses cancer prevention and risk reduction.
Read more.
|
Every month, we huddle for another edition of Across the Consortium to recap the progress of our member institutions.
Read more.
|
Advancing against breast cancer
|
October is National Breast Cancer Awareness Month - a time to engage, mobilize, and learn - and the Big Ten Cancer Research Consortium brings a wealth of progress to the table. This month, we focus on the advances our members are making against breast cancer.
Read more
.
|
|
|